EIM
ARRY

Essex Investment Management’s Array Biopharma Inc ARRY Stock Holding History

Essex Investment Management’s Portfolio ARRY Stock Details ARRY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-10,791
Closed -$164K – 566
2018
Q3 		$164K Buy
+10,791
New +$165K 0.02% 389

Other funds holding ARRY

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

Essex Investment Management's ARRY Position: Q4 2018 in Review

Essex Investment Management sold out of Array Biopharma Inc (ARRY) in Q4 2018, closing a stake of 10,791 shares — an estimated $164K sold.

Essex Investment Management first reported a position in ARRY in Q3 2018 and held it in 1 quarter. The position peaked at $164K in Q3 2018. 236 funds tracked by Wall St. Rank hold ARRY as of Q4 2018.

  • Essex Investment Management reported no remaining Array Biopharma Inc position as of Q4 2018 after selling out during the quarter.
  • Essex Investment Management sold 10,791 Array Biopharma Inc shares in Q4 2018, an estimated $164K.
  • Essex Investment Management first reported a position in Array Biopharma Inc in Q3 2018 and held it in 1 quarter.
  • Essex Investment Management's Array Biopharma Inc position peaked at $164K in Q3 2018.
  • 236 funds tracked by Wall St. Rank held Array Biopharma Inc as of Q4 2018.

Based on Essex Investment Management's 13F filing for Q4 2018, filed 6 Feb 2019.